Professional Documents
Culture Documents
Pharma Finals
Pharma Finals
ADVERSE EFFECT
-Oliguria (low urine output) RESPIRATORY SYSTEM
Oxygen > nose/mouth > back of the
INFLAMMATION throat (trachea) > left or right lung
through bronchus > bronchioles >
Acute alveolus > capillaries
➢ Immediate onset
➢ Resole and repair
Chronic
Air into blood- diffusion
➢ Slow onset
➢ Prolonged period 300 million alveoli each lung
➢ Autoimmune 12-16 bpm
Cilla- tiny little hairs
PHARMACOTHERAY FOR Goblet cells- release mucus
INFLAMMATION
Non-Steroidal Anti-Inflammatory Drugs
(NSAIDS) UPPER RESPIRATORY TRACT
ADVERSE EFFECT
Therapeutic Goal
➢ Burning sensation of the nose
Preventers Relievers ➢ Drying of nasal mucosa
prophylaxis Immediate but ➢ Alternative: montelukast and
temporary ipratropium
Antihistamines Oral and nasal
decongestants
Intranasal
corticosteroids FLUTICASONE
Mast cell ➢ Perineal allergic rhinitis
stabilizer
➢ 2 sprays each nostril 2x a day
decrease to 1 dose
*nurses should identify the allergy ➢ Pregnancy c
DECONGESTANTS MYCOLYTICS
OXYMETAZOLINE - to loosen thick
PC: sympathomimetic ACETYLCESTEINE
➢ alpha adrenergic - Mucus becomes thinner
- Drug that is intended to loosen thick,
viscous bronchial secretions and to
ADVERSE EFFECT remove mucous through coughing.
ADVERSE EFFECT
ANTICOLLIGERNICS - Headache
- Nausea
- blocks parasympathetic
- Diarrhea
IPRATOPIUM
- Pregnancy B
MAST CELL STABILIZER
Prophylaxis- prevent attack
- Inhibiting the release of histamines
- 14 days prior
CROMOLYN
NECLOCROMIL
MUNOCLONAL ANTIBODIES
OLIMAZILUMAB
➢ Anti-cancer
➢ Severe
➢ 12 yrs old below
➢ 2-4 weeks
➢ Expensive
➢ Resistant asthma